Company
Biohaven Ltd. (BHVN)
Standardized SEC financial data for Biohaven Ltd. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001935979 · NYSE · Pharmaceutical Preparations.
Return on equity
-1000.0%
Free cash flow
-$610.2M
Current ratio
3.18×
EPS (diluted)
$-6.86
Income statement
| USD | FY2021 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $181.5M | — | $437.1M | $373.3M | $795.9M | $635.1M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $83.5M | $77.1M | $242.6M | $252.1M | $102.5M | $232.8M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$76.0M | -$145.8M | -$297.7M | -$331.7M | -$582.5M | -$609.4M |
| Capital expenditures |
Get BHVN data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/BHVN/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/BHVN/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"